BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26599519)

  • 21. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes.
    Bollini M; Casal JJ; Bruno AM
    Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
    Lu A; Luo H; Shi M; Wu G; Yuan Y; Liu J; Tang F
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4924-7. PubMed ID: 21741834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies.
    Raffa D; Maggio B; Cascioferro S; Raimondi MV; Daidone G; Plescia S; Schillaci D; Cusimano MG; Titone L; Colomba C; Tolomeo M
    Arch Pharm (Weinheim); 2009 May; 342(5):265-73. PubMed ID: 19415659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Akt kinase inhibitors through structure-based virtual screening and their evaluation as potential anticancer agents.
    Chuang CH; Cheng TC; Leu YL; Chuang KH; Tzou SC; Chen CS
    Int J Mol Sci; 2015 Feb; 16(2):3202-12. PubMed ID: 25648320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
    Arjmand F; Yousuf I; Hadda Tb; Toupet L
    Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity.
    Subtel'na I; Atamanyuk D; Szymańska E; Kieć-Kononowicz K; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
    Bioorg Med Chem; 2010 Jul; 18(14):5090-102. PubMed ID: 20594860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.
    Kim DK; Lee JY; Kim JS; Ryu JH; Choi JY; Lee JW; Im GJ; Kim TK; Seo JW; Park HJ; Yoo J; Park JH; Kim TY; Bang YJ
    J Med Chem; 2003 Dec; 46(26):5745-51. PubMed ID: 14667227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II.
    Shanab K; Schirmer E; Wulz E; Weissenbacher B; Lassnig S; Slanz R; Fösleitner G; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
    Bioorg Med Chem Lett; 2011 May; 21(10):3117-21. PubMed ID: 21458262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and antiproliferative activities of novel benzamides derivatives as HDAC inhibitors.
    Li Y; Wang Y; Xie N; Xu M; Qian P; Zhao Y; Li S
    Eur J Med Chem; 2015 Jul; 100():270-6. PubMed ID: 26140961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.
    Rotili D; De Luca A; Tarantino D; Pezzola S; Forgione M; Morozzo Della Rocca B; Falconi M; Mai A; Caccuri AM
    Eur J Med Chem; 2015 Jan; 89():156-71. PubMed ID: 25462236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and anticancer activities of ageladine A and structural analogs.
    Ma Y; Nam S; Jove R; Yakushijin K; Horne DA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):83-6. PubMed ID: 19948404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
    Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
    Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
    Neugebauer RC; Uchiechowska U; Meier R; Hruby H; Valkov V; Verdin E; Sippl W; Jung M
    J Med Chem; 2008 Mar; 51(5):1203-13. PubMed ID: 18269226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
    Congiu C; Cocco MT; Onnis V
    Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
    Brasca MG; Nesi M; Avanzi N; Ballinari D; Bandiera T; Bertrand J; Bindi S; Canevari G; Carenzi D; Casero D; Ceriani L; Ciomei M; Cirla A; Colombo M; Cribioli S; Cristiani C; Della Vedova F; Fachin G; Fasolini M; Felder ER; Galvani A; Isacchi A; Mirizzi D; Motto I; Panzeri A; Pesenti E; Vianello P; Gnocchi P; Donati D
    Bioorg Med Chem; 2014 Sep; 22(17):4998-5012. PubMed ID: 25009002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
    Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
    J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents.
    Lisowski V; Léonce S; Kraus-Berthier L; Sopková-de Oliveira Santos J; Pierré A; Atassi G; Caignard DH; Renard P; Rault S
    J Med Chem; 2004 Mar; 47(6):1448-64. PubMed ID: 14998333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.